Indices may open with modest gains following mixed cues from Asian peers
Indices may open with modest gains following mixed cues from Asian peers

Indices may open with modest gains following mixed cues from Asian peers

Karan Dsij Article rating: 4.5

Indian indices are likely to open with modest gains as cues from Asia markets are mixed.  The SGX Nifty indicates Nifty is likely to open around 10,861, up by 20 points. The earnings of Yes Bank, Ultratech Cement, Sunteck, Sterlite Technologies, PVR, Pfizer, NIIT Ltd, Mphasis, Biocon, Colgate Palmolive are scheduled for today. 

Types of Health Insurance
Types of Health Insurance

Types of Health Insurance

Henil Shah Article rating: 3.3

Before going for any health insurance plan you must know what are the different types of health insurance so that you can pick the right one. Read on to find out more.

Essel Propack reports PAT rise of 14 per cent for Q3FY19
Essel Propack reports PAT rise of 14 per cent for Q3FY19

Essel Propack reports PAT rise of 14 per cent for Q3FY19

Pratik Shastri Article rating: 4.7

Essel Propack Limited reported its results for the quarter ended December 31, 2018 after market hours on Wednesday. The consolidated numbers were largely stable and in-line with street estimates.

Indigo: PAT plunges 75 per cent in Q3
Indigo: PAT plunges 75 per cent in Q3

Indigo: PAT plunges 75 per cent in Q3

Aakash Makhija Article rating: 5.0
The EBITDAR for the quarter fell by 16% yoy to Rs. 1681.4 crore as against Rs.  2001.9 crore in the corresponding quarter last year, with a corresponding margin contraction of 1120 bps. EBITDAR margin for the quarter stood at 21.2%
BHEL secures additional order from Mahagenco
BHEL secures additional order from Mahagenco

BHEL secures additional order from Mahagenco

Pratik Shastri Article rating: 5.0

Bharat Heavy Electrical Limited (BHEL), country's leading PSU, bagged order from Maharashtra State Power Generation Company (Mahagenco) for power project's emission control equipment.

Results to watch out on Thursday, January 24
Results to watch out on Thursday, January 24

Results to watch out on Thursday, January 24

Shohini Nath Article rating: 4.3

The following stocks would be in focus during Thursday’s trading session in light of their results announcement on January 24: Biocon, Jyothy Laboratories, PVR, Yes Bank and Supreme Industries.

Can Fin Homes PAT jumps 21 per cent
Can Fin Homes PAT jumps 21 per cent

Can Fin Homes PAT jumps 21 per cent

Nidhi Jani Article rating: 5.0

The company’s net interest income (NII) for the quarter came in at Rs 136 crore as against Rs 127 crore in the corresponding quarter last year, registering 6.9 per cent increase on a yoy basis.

Premier Explosives surges 16 per cent post results
Premier Explosives surges 16 per cent post results

Premier Explosives surges 16 per cent post results

Gayathri Udyawar Article rating: 5.0

The stock of Premier Explosives was on a northward spree on Wednesday following the company's result announcement for the December quarter. The company's profit jumped 4-folds in Q3FY19.

Q3FY19 Results: ITC revenue up 15 per cent
Q3FY19 Results: ITC revenue up 15 per cent

Q3FY19 Results: ITC revenue up 15 per cent

Nidhi Jani Article rating: 4.0

The revenue from cigarettes grew by 9.6 per cent YoY. Also, the revenue from hotels, agribusiness and packaging grew by 11.7 per cent, 25.7 per cent and 20.5 per cent, respectively on YoY basis.

Glenmark Pharma: USFDA approves Abiraterone Acetate Tablets USP
Glenmark Pharma: USFDA approves Abiraterone Acetate Tablets USP

Glenmark Pharma: USFDA approves Abiraterone Acetate Tablets USP

Pratik Shastri Article rating: 2.5

Glenmark  Pharma has received approval from the United States Food & Drug Administration (USFDA) for Abiraterone Acetate Tablets USP, 250 mg. The drug is a generic version of Zytiga tablet sold by Janssen Biotech.

RSS
First30643065306630673069307130723073Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR